Erlotinib-induced dermatologic side-effects
Author:
Publisher
Wiley
Subject
Dermatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-4632.2009.03835.x/fullpdf
Reference10 articles.
1. Clinical signs, pathophysiology and management of skin toxicity during therapy with epidermal growth factor receptor inhibitors;Segaert;Ann Oncol,2005
2. Dermatologic side effects associated with the epidermal growth factor receptor inhibitors;Agero;J Am Acad Dermatol,2006
3. Erlotinib-associated skin reactions - case report and proposal for classification;Zoller;Br J Dermatol,2006
4. The EGF receptor - an essential regulator of epidermal functions;Jost;Eur J Dermatol,2000
5. Pharmacodynamic studies of the epidermal growth factor receptor inhibitor ZD 1839 in skin from cancer patients: histopathologic and molecular consequences of receptor inhibition;Albanell;J Clin Oncol,2002
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Dual stimuli-responsive release of aptamer AS1411 decorated erlotinib loaded chitosan nanoparticles for non-small-cell lung carcinoma therapy;Carbohydrate Polymers;2020-10
2. Improved oral bioavailability and therapeutic efficacy of erlotinib through molecular complexation with phospholipid;International Journal of Pharmaceutics;2017-12
3. Development and in vitro evaluation of core–shell type lipid–polymer hybrid nanoparticles for the delivery of erlotinib in non-small cell lung cancer;European Journal of Pharmaceutical Sciences;2016-01
4. Folliculitis Induced by EGFR Inhibitors, Preventive and Curative Efficacy of Tetracyclines in the Management and Incidence Rates According to the Type of EGFR Inhibitor Administered: A Systematic Literature Review;The Oncologist;2012-03-16
5. Erlotinib inhibits T-cell-mediated immune response via down-regulation of the c-Raf/ERK cascade and Akt signaling pathway;Toxicology and Applied Pharmacology;2011-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3